
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Kronos Bio
Kronos Bio, Inc. operates as a biotechnology company. The Company discovers and develops therapies that modulate historically recalcitrant cancer targets. Kronos Bio serves customers in worldwide.
Stock Analysis

last close
$4.89
1-mo return
13.2%
3-mo return
22.3%
avg daily vol.
254.63T
52-week high
25.01
52-week low
2.96
market cap.
$315M
forward pe
-
annual div.
-
roe
-46.1%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
67.1%